Breaking News Instant updates and real-time market news.

MRK

Merck

$63.89

0.89 (1.41%)

, INCY

Incyte

$128.80

8.31 (6.90%)

08:50
05/19/17
05/19
08:50
05/19/17
08:50

Merck leadership in NSCLC 'solidified,' says BMO Capital

BMO Capital analyst Alex Arfaei says that "the ASCO abstracts solidify Merck's (MRK) significant leadership in the important 1L-NSCLC market." The analyst says that Incyte's (INCY) Epacadostat appears to be "adding meaningful clinical benefit to Keytruda." He believes that the data "clearly indicates" that Keytruda monotherapy should be the standard of care in about 25% of 1L-NSCLC patients.

MRK

Merck

$63.89

0.89 (1.41%)

INCY

Incyte

$128.80

8.31 (6.90%)

  • 22

    May

  • 23

    May

  • 27

    May

  • 31

    May

  • 02

    Jun

  • 05

    Jun

  • 09

    Jun

  • 14

    Jun

MRK Merck
$63.89

0.89 (1.41%)

04/04/17
STFL
04/04/17
NO CHANGE
STFL
NewLink Genetics should be bought on weakness after data, says Stifel
Stifel analyst Stephen Willey said NewLink Genetics' (NLNK) combination of indoximod and Merck's (MRK) pembrolizumab in patients with treatment-naive melanoma demonstrated an overall response rate, or ORR, that is "essentially identical" to the previously-reported results from the Incyte (INCY)-Merck study of epacadostat/pembrolizumab. The lower rate of complete responses he doesn't "find terribly surprising" given what is already known about the current indoximod formulation, he tells investors. Willey, who views today's weakness as an interesting buying opportunity ahead of P1/2 data on the atezolizumab + GDC-0919 combination, keeps a Buy rating on Newlink shares.
04/20/17
JEFF
04/20/17
NO CHANGE
Target $51
JEFF
Underperform
Jefferies lowers Merck estimates, drops target to $51
Jefferies analyst Jeffrey Holford lowered his earnings estimates for Merck by up to 3% citing concerns on pricing for Januvia/Janumet. The analyst notes that his mid-term estimates are now up to 11% below consensus. Holford expects Keytruda, Januvia and Gardasil to miss expectations Q1. He cut his price target for Merck to $51 from $52 and keeps an Underperform rating on the name.
05/03/17
BMOC
05/03/17
NO CHANGE
BMOC
Merck results more positive than first appeared, says BMO Capital
BMO Capital analyst Alex Arfaei says he's more upbeat on Merck's Q1 results following its conference call. He says that the lower than expected Januvia revenue is "explainable," while the company's Keytruda drug looks set to beat expectations in 2H17. The analyst expects the company's 2017 results to come in at the top half of its guidance range, and he thinks the stock can rise, driven by Keytruda and its hepatitis C treatments. The analyst keeps an Outperform rating on the shares.
05/11/17
BMOC
05/11/17
NO CHANGE
BMOC
Merck Keytruda approval positive, says BMO Capital
BMO Capital analyst Alex Arfaei notes that the FDA approved Keytruda + chemo in first line NSCLC. The analyst says that the label is "solid," and he expects "strong uptake" for the drug in the condition, based on his checks with oncologists. The analyst raised his price target on the shares to $74 from $71 and keeps an Outperform rating on the stock.
INCY Incyte
$128.80

8.31 (6.90%)

05/09/17
FBCO
05/09/17
NO CHANGE
Target $152
FBCO
Outperform
Incyte price target lowered to $152 from $167 at Credit Suisse
Credit Suisse analyst Alethia Young lowered her price target for Incyte to $152 from $167 due to moving from M&A base case valuation. While the analyst says it is possible that one day Incyte is bought, she thinks the company is progressing well in diversifying its pipeline base and de-risking its IDO inhibitor epacadostat. Young reiterates an Outperform rating on the shares.
05/11/17
OPCO
05/11/17
INITIATION
Target $125
OPCO
Perform
Incyte initiated with a Perform at Oppenheimer
Oppenheimer analyst Jay Olson initiated Incyte with a Perform and a $125 price target to reflect the valuation premium driven by takeover speculation. The analyst has no insight into the speculation but also said expectations are high going into ASCO for Incyte's epacadostat to deliver impressive benefits in combo with Keytrude in lung cancer.
05/18/17
JPMS
05/18/17
NO CHANGE
Target $149
JPMS
Overweight
Incyte data to 'restore positive sentiment,' says JPMorgan
JPMorgan analyst Cory Kasimov believes last night's abstracts for epacadostat demonstrate "consistent and compelling evidence" of efficacy across multiple tumor types, consistent with what Incyte has been telling with Street. The analyst is "encouraged" by emerging data and expect it will "restore positive sentiment" in the name and add to the company's perceived strategic value. He reiterates an Overweight rating on Incyte shares with a $149 price target.
05/18/17
BMOC
05/18/17
NO CHANGE
BMOC
Incyte price target raised to $155 from $146 at BMO Capital
BMO Capital analyst M. Ian Somaiya raised his price target on Incyte as he increased the chances of success of the company's epacadostat + PD-1 combination in four solid tumors following favorable data. The analyst adds that the combination's position was also helped by "lackluster" data on NewLink's (NLNK) IDO, drug, GDC-0919. He raised his price target on Incyte to $155 from $146.

TODAY'S FREE FLY STORIES

02:25
07/27/17
07/27
02:25
07/27/17
02:25
General news
FX Update: The Fed's statement has put the dollar under the cosh »

FX Update: The…

01:30
07/27/17
07/27
01:30
07/27/17
01:30
General news
FX Action: USD-JPY logged a low at 110.78 »

FX Action: USD-JPY logged…

RETA

Reata Pharmaceuticals

$32.06

-0.46 (-1.41%)

22:11
07/26/17
07/26
22:11
07/26/17
22:11
Syndicate
Reata Pharmaceuticals 3.25M share Secondary priced at $31.00 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Jul

SNNA

Sienna Biopharmaceuticals

22:03
07/26/17
07/26
22:03
07/26/17
22:03
Syndicate
Sienna Biopharmaceuticals 4.3M share IPO priced at $15.00 »

The deal priced between…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

PG

Procter & Gamble

$89.30

0.16 (0.18%)

, BUD

AB InBev

$115.71

1.75 (1.54%)

20:25
07/26/17
07/26
20:25
07/26/17
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

PG

Procter & Gamble

$89.30

0.16 (0.18%)

BUD

AB InBev

$115.71

1.75 (1.54%)

CMCSA

Comcast

$39.35

-0.4 (-1.01%)

CMCSK

Comcast

VZ

Verizon

$44.40

0.42 (0.95%)

MO

Altria Group

$71.73

-0.51 (-0.71%)

CELG

Celgene

$137.75

1.31 (0.96%)

CHTR

Charter

$348.77

0.77 (0.22%)

UPS

UPS

$112.29

-0.93 (-0.82%)

BMY

Bristol-Myers

$55.98

0.03 (0.05%)

DOW

Dow Chemical

$66.42

-0.43 (-0.64%)

COP

ConocoPhillips

$43.70

0.05 (0.11%)

RTN

Raytheon

$168.88

-0.71 (-0.42%)

ADP

ADP

$105.98

2.8 (2.71%)

JCI

Johnson Controls

$43.32

-0.86 (-1.95%)

LUV

Southwest

$59.52

0.7 (1.19%)

MCK

McKesson

$166.35

-1.28 (-0.76%)

PCG

PG&E

$67.90

0.39 (0.58%)

VLO

Valero

$67.99

-0.45 (-0.66%)

ALXN

Alexion

$131.07

1.72 (1.33%)

ZBH

Zimmer Biomet

$128.70

-0.07 (-0.05%)

MGM

MGM Resorts

$33.87

-0.4 (-1.17%)

DPS

Dr Pepper Snapple

$92.15

0.26 (0.28%)

KKR

KKR

$19.31

-0.15 (-0.77%)

TWTR

Twitter

$19.61

-0.36 (-1.80%)

LLL

L3 Technologies

$175.52

-1.79 (-1.01%)

NLSN

Nielsen

$39.89

1.27 (3.29%)

DNKN

Dunkin' Brands

$52.52

-0.71 (-1.33%)

WIX

Wix.com

$76.85

0.9 (1.19%)

TREE

LendingTree

$183.80

-2.25 (-1.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 30

    Jul

  • 02

    Aug

  • 06

    Aug

  • 07

    Aug

  • 07

    Aug

  • 08

    Aug

  • 08

    Aug

  • 08

    Aug

  • 10

    Aug

  • 14

    Aug

  • 21

    Aug

  • 29

    Aug

  • 30

    Aug

  • 11

    Sep

  • 13

    Sep

  • 19

    Sep

  • 20

    Sep

  • 21

    Sep

  • 24

    Sep

  • 23

    Oct

  • 09

    Nov

  • 05

    Mar

DISCA

Discovery

$26.58

0.65 (2.51%)

, SNI

Scripps Networks

$84.07

2.62 (3.22%)

19:33
07/26/17
07/26
19:33
07/26/17
19:33
Periodicals
Discovery in lead to buy Scripps, Reuters says »

Discovery (DISCA) has…

DISCA

Discovery

$26.58

0.65 (2.51%)

SNI

Scripps Networks

$84.07

2.62 (3.22%)

VIA

Viacom

$39.75

-0.6 (-1.49%)

VIAB

Viacom

$34.37

-0.64 (-1.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Aug

  • 09

    Aug

VIA

Viacom

$39.75

-0.6 (-1.49%)

, VIAB

Viacom

$34.37

-0.64 (-1.83%)

19:30
07/26/17
07/26
19:30
07/26/17
19:30
Periodicals
Breaking Periodicals news story on Viacom, Viacom »

Viacom drops bidding for…

VIA

Viacom

$39.75

-0.6 (-1.49%)

VIAB

Viacom

$34.37

-0.64 (-1.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Aug

DISCA

Discovery

$26.58

0.65 (2.51%)

, SNI

Scripps Networks

$84.07

2.62 (3.22%)

19:28
07/26/17
07/26
19:28
07/26/17
19:28
Periodicals
Discovery offer for Scripps deemed superior to Viacom's, CNBC's Faber says »

Scripps (SNI) will enter…

DISCA

Discovery

$26.58

0.65 (2.51%)

SNI

Scripps Networks

$84.07

2.62 (3.22%)

VIA

Viacom

$39.75

-0.6 (-1.49%)

VIAB

Viacom

$34.37

-0.64 (-1.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Aug

  • 09

    Aug

CRAY

Cray

$18.60

-0.3 (-1.59%)

, STX

Seagate

$32.34

-0.86 (-2.59%)

19:18
07/26/17
07/26
19:18
07/26/17
19:18
Hot Stocks
Cray, Seagate enter partnership centered around ClusterStor »

Cray (CRAY) announced it…

CRAY

Cray

$18.60

-0.3 (-1.59%)

STX

Seagate

$32.34

-0.86 (-2.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

MDXG

MiMedx

$14.65

-0.22 (-1.48%)

19:18
07/26/17
07/26
19:18
07/26/17
19:18
Earnings
MiMedx backs FY17 adjusted EPS view of 31c-33c, consensus 30c »

Raises FY17 revenue view…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

  • 13

    Nov

  • 14

    Nov

MDXG

MiMedx

$14.65

-0.22 (-1.48%)

19:17
07/26/17
07/26
19:17
07/26/17
19:17
Earnings
Breaking Earnings news story on MiMedx »

MiMedx sees Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

  • 13

    Nov

  • 14

    Nov

MDXG

MiMedx

$14.65

-0.22 (-1.48%)

19:16
07/26/17
07/26
19:16
07/26/17
19:16
Earnings
MiMedx reports Q2 EPS 7c, consensus 7c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

  • 13

    Nov

  • 14

    Nov

GE

General Electric

$25.59

0.15 (0.59%)

, AEP

American Electric

$69.45

0.61 (0.89%)

19:08
07/26/17
07/26
19:08
07/26/17
19:08
Hot Stocks
Invenergy, GE to build 2,000 megawatt wind farm in Oklahoma »

Invenergy, along with GE…

GE

General Electric

$25.59

0.15 (0.59%)

AEP

American Electric

$69.45

0.61 (0.89%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

  • 02

    Oct

PSA

Public Storage

$210.06

2.34 (1.13%)

19:05
07/26/17
07/26
19:05
07/26/17
19:05
Earnings
Pure Storage reports Q2 core FFO $2.51, consensus $2.54 »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

BRK.A

Berkshire Hathaway

$259,600.00

189.98 (0.07%)

, BRK.B

Berkshire Hathaway

$173.02

0.08 (0.05%)

18:57
07/26/17
07/26
18:57
07/26/17
18:57
Periodicals
Breaking Periodicals news story on Berkshire Hathaway, Berkshire Hathaway »

Elliott wins short delay…

BRK.A

Berkshire Hathaway

$259,600.00

189.98 (0.07%)

BRK.B

Berkshire Hathaway

$173.02

0.08 (0.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AXTI

AXT, Inc.

$7.60

0.25 (3.40%)

18:43
07/26/17
07/26
18:43
07/26/17
18:43
Earnings
AXT, Inc. sees Q3 EPS 8c-10c, consensus 7c »

Sees Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 03

    Aug

  • 10

    Aug

  • 19

    Sep

NGD

New Gold

$3.17

0.15 (4.97%)

18:42
07/26/17
07/26
18:42
07/26/17
18:42
Hot Stocks
New Gold names Paula Myson as CFO »

Myson has over 25 years…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

NGD

New Gold

$3.17

0.15 (4.97%)

18:40
07/26/17
07/26
18:40
07/26/17
18:40
Earnings
New Gold reports Q2 adjusted EPS 2c, consensus 2c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

PKG

Packaging Corp.

$108.80

0.22 (0.20%)

18:37
07/26/17
07/26
18:37
07/26/17
18:37
Earnings
Packaging Corp. sees Q3 EPS $1.68, consensus $1.66 »

Looking ahead to the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

  • 12

    Sep

PKG

Packaging Corp.

$108.80

0.22 (0.20%)

18:36
07/26/17
07/26
18:36
07/26/17
18:36
Earnings
Packaging Corp. reports Q2 adjusted EPS $1.52, consensus $1.47 »

Reports Q2 revenue $1.6B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

  • 12

    Sep

CUBI

Customers Bancorp

$28.24

-0.25 (-0.88%)

18:31
07/26/17
07/26
18:31
07/26/17
18:31
Hot Stocks
Customers Bank expands private, commercial banking unit into Chicago »

Customers Bank announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

HNHPF

Hon Hai Precision

$7.70

-0.02 (-0.26%)

18:21
07/26/17
07/26
18:21
07/26/17
18:21
Hot Stocks
White House welcomes Foxconn announcement of LCD panel plant in Wisconsin »

President Donald J. Trump…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NFBK

Northfield Bancorp

$16.69

-0.34 (-2.00%)

18:15
07/26/17
07/26
18:15
07/26/17
18:15
Earnings
Northfield Bancorp reports Q2 EPS 18c, consensus 16c »

Net interest income for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

TXN

Texas Instruments

$82.53

1.14 (1.40%)

18:10
07/26/17
07/26
18:10
07/26/17
18:10
Periodicals
Texas Instruments' strong results, outlook signal further upside, Barron's says »

Texas Instruments…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Aug

FIBK

First Interstate

$36.55

-0.7 (-1.88%)

18:09
07/26/17
07/26
18:09
07/26/17
18:09
Earnings
First Interstate reports Q2 core EPS 59c, consensus 56c »

The company's net…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.